Gut microbiome and metabolism alterations in schizophrenia with metabolic syndrome severity

Abstract Background Schizophrenia (SCZ) patients undergoing antipsychotic treatment demonstrated a high prevalence and harmful effects of metabolic syndrome (MetS), which acted as the major cause of cardiovascular disease. The major clinical challenge is the lack of biomarkers to identify MetS episo...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hongxia Zhao, Guang Zhu, Tong Zhu, Binbin Ding, Ahong Xu, Songyan Gao, Yufan Chao, Na Li, Yongchun Chen, Zuowei Wang, Yong Jie, Xin Dong
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2024-07-01
Col·lecció:	BMC Psychiatry
Matèries:	Multi–omics Schizophrenia Metabolic syndrome Biomarker
Accés en línia:	https://doi.org/10.1186/s12888-024-05969-9
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!